TC Medical(SH:600763) Sou Hu Cai Jing·2025-11-05 11:29Core Viewpoint - Tongce Medical (600763) experienced a decline in stock price, closing at 42.37 yuan on November 5, 2025, with a trading volume of 40,500 hands and a turnover of 172 million yuan [1] Group 1: Stock Performance - On November 5, 2025, the stock price decreased by 0.91% with a turnover rate of 0.91% [1] - The net outflow of main funds was 20.30 million yuan, accounting for 11.79% of the total turnover, while retail investors saw a net inflow of 22.47 million yuan, representing 13.05% of the total turnover [1][2] Group 2: Financial Metrics - As of the third quarter of 2025, Tongce Medical reported a total revenue of 2.29 billion yuan, a year-on-year increase of 2.56%, and a net profit of 514 million yuan, up 3.16% year-on-year [3] - The company’s gross profit margin stood at 41.69%, significantly higher than the industry average of 35.56% [3] - The company’s return on equity (ROE) was 11.8%, compared to the industry average of 3.24% [3] Group 3: Institutional Ratings - In the last 90 days, 10 institutions provided ratings for the stock, with 8 buy ratings and 2 hold ratings, and the average target price set at 52.01 yuan [4]